Pulmonx Corporation
LUNG
$1.62
-$0.01-0.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.96M | -15.17M | -14.45M | -13.18M | -14.14M |
| Total Depreciation and Amortization | 246.00K | 299.00K | 278.00K | 294.00K | 376.00K |
| Total Amortization of Deferred Charges | 14.00K | 13.00K | 11.00K | 1.73M | 11.00K |
| Total Other Non-Cash Items | 5.66M | 6.29M | 5.72M | 3.63M | 5.69M |
| Change in Net Operating Assets | -128.00K | 4.67M | -4.78M | 789.00K | 825.00K |
| Cash from Operations | -8.16M | -3.91M | -13.22M | -6.73M | -7.24M |
| Capital Expenditure | -89.00K | -49.00K | -301.00K | -111.00K | -416.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.80M | 5.52M | 16.61M | 14.18M | 7.17M |
| Cash from Investing | 8.71M | 5.47M | 16.31M | 14.07M | 6.75M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.00K | -48.00K | -- | -49.00K | 0.00 |
| Issuance of Common Stock | 205.00K | 28.00K | 664.00K | 111.00K | 459.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -23.00K | -47.00K | -- | -- | -- |
| Cash from Financing | 181.00K | -67.00K | 664.00K | 62.00K | 459.00K |
| Foreign Exchange rate Adjustments | 355.00K | -583.00K | -105.00K | 193.00K | -119.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.09M | 913.00K | 3.65M | 7.59M | -151.00K |